Detalles de la búsqueda
1.
[PERIOPERATIVE MANAGEMENT OF PATIENTS WITH DIABETES MELLITUS.]
Anesteziol Reanimatol
; 61(4): 290-293, 2016 Jul.
Artículo
en Ruso
| MEDLINE | ID: mdl-29470899
2.
PREVENTION OF HEART FAILURE PATIENTS WITH DECREASED EJECTION FRACTION IN NON-CARDIAC SURGERY: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION?.
Anesteziol Reanimatol
; 61(6): 411-417, 2016 Nov.
Artículo
en Inglés, Ruso
| MEDLINE | ID: mdl-29894607
3.
EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.
Bone Marrow Transplant
; 42(3): 181-6, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18516079
4.
Impact of molecular residual disease post allografting in myelofibrosis patients.
Bone Marrow Transplant
; 52(11): 1526-1529, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28714945
5.
Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Bone Marrow Transplant
; 37(1): 45-50, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16258531
6.
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).
Bone Marrow Transplant
; 37(4): 339-44, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16415898
7.
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.
Bone Marrow Transplant
; 37(2): 155-63, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16284608
8.
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.
Leukemia
; 19(1): 7-12, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15526016
9.
Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis.
Bone Marrow Transplant
; 51(9): 1223-7, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27088376
10.
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 31(9): 817-22, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12732891
11.
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
Bone Marrow Transplant
; 27(4): 349-54, 2001 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11313663
12.
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Bone Marrow Transplant
; 28(7): 643-7, 2001 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-11704786
13.
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.
Bone Marrow Transplant
; 33(5): 483-90, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14716342
14.
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Bone Marrow Transplant
; 23(9): 889-93, 1999 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10338043
15.
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.
Bone Marrow Transplant
; 29(8): 683-9, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12180114
16.
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Bone Marrow Transplant
; 26(7): 711-6, 2000 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-11042650
17.
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone Marrow Transplant
; 32(4): 355-61, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12900771
18.
Syostri (Sisters): the Moscow Sexual Assault Recovery Center.
Violence Against Women
; 1(3): 266-71, 1995 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12322336
19.
[Experience with using cefoperazone in cancer patients after bone marrow transplantation]. / Opyt primeneniia tsefoperazona u onkologicheskikh bol'nykh posle transplantatsii kostnogo mozga.
Antibiot Khimioter
; 37(8): 14-5, 1992 Aug.
Artículo
en Ruso
| MEDLINE | ID: mdl-1456815
20.
[Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside]. / Terapiia bol'nykh mieloidnymi leikozami malymi dozami tsitozinarabinozida.
Ter Arkh
; 59(12): 81-6, 1987.
Artículo
en Ruso
| MEDLINE | ID: mdl-3482131